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Radioisotope studies in cardiology have been a standard 
for myocardial perfusion and function assessment since the late 
seventies. The rapid development of echocardiography, computed 
tomography and cardiovascular magnetic resonance provided 
new insight into the diagnostic role of nuclear cardiology. However 
the strengths of cardiac nuclear medicine include: reliance on 
physiology rather than anatomic definition (can be combined with 
anatomical images); standardized and efficient techniques that 
can be performed in academic centers and in small hospitals; 
a large body of evidence-based supporting clinical data. 
The current issue of Nuclear Medicine Review is almost entirely 
on the nuclear methods of cardiac imaging in various clinical set-
tings. The majority of papers are on the perfusion imaging. The 
authors from Szczecin confirmed the strong prognostic value 
of SPECT in their unselected population. That is also true for 
patients with stenosed coronary arteries. Normal SPECT scan 
has an excellent prognosis as it was proven by researchers from 
Cracow. Moreover myocardial perfusion SPECT study serving 
as the prognostic tool may be even superior to coronary angiog-
raphy in women as it was concluded in the paper from Warsaw. 
Heart failure and associated arrhythmias are major clinical 
problems and MIBG imaging provides important prognostic 
information as well as the myocardial perfusion imaging. In the 
interesting paper from Lublin the cardiac sympathetic dysfunction 
was assessed in hemodialysed patients. A broader view was pre-
sented in the review article from Institute of Cardialogy, Warsaw. 
Highly accurate and repetitive nuclear cardiology tech-
niques have always been used for the serial assessment of pa-
tients. Detrimental effects of the chemotherapy on human heart 
assessed by the gated equilibrium ventriculography is discussed 
in the original paper from the Centre of Oncology, Warsaw. 
This issue of the journal contains an interesting paper from 
Warsaw University Hospital about the myocardial viability assessed 
with PET-CT coupled with the very informative cases. More general 
review paper by Misko describes the role of myocardial perfusion 
imaging and viability in relation to the current revascularization 
guidelines. 
Dear Sirs and Madams,
There are interesting case reports. The authors from Warsaw 
describe the course of the coronary artery disease in a patient with 
the ST elevation during the radioisotope stress test. The cardiac 
patients are often unpredictable. The uncommon vascular anomaly 
diagnosed with multi modal cardiac examinations is presented by 
the colleagues from Cracow. Another case shows great efficacy 
of the PET-CT imaging in myocardial sarcoma patient. 
In order to show to the cardiac community other strengths of 
nuclear medicine there is a paper from Bialystok on the radioio-
dine treatment of the toxic nodular goitre. The nuclear medicine 
methods are safe and the patients should not be afraid of radia-
tion. This topic has been thoroughly discussed in the review paper 
from Lodz. 
It is time to accept that myocardial perfusion SPECT and PET 
in cardiology have to compete with other modalities. Despite the 
fact that nuclear cardiology measures perfusion better than all 
other tomographic methods — they image much more of the heart 
and great vessels. However there is a hope in further technological 
improvement such as the new gamma cameras based on the CZT 
semiconductor detectors which is already available in Warsaw. 
More expectations are associated with the new PET tracers for 
myocardial perfusion, innervation and metabolism imaging. The 
newly opened cyclotron centres in Cracow and Kielce show prom-
ise for the future development of the nuclear medicine techniques. 
With this edition of Nuclear Medicine Review we confirm that 
nuclear cardiology is and will continue to be an integral part of 
the diagnosis and management of coronary artery disease. The 
creativity and pragmatism of nuclear medicine community will 
result in the development of new agents and nuclear techniques. 
This will help the nuclear cardiology to remain vital diagnostic tool 
within the expanding field of cardiovascular imaging.
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